Royce & Associates LP Has $33.56 Million Stock Holdings in Aspen Aerogels, Inc. (NYSE:ASPN)

Royce & Associates LP decreased its stake in Aspen Aerogels, Inc. (NYSE:ASPN) by 2.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,212,097 shares of the construction company’s stock after selling 27,170 shares during the quarter. Royce & Associates LP’s holdings in Aspen Aerogels were worth $33,563,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. Point72 Hong Kong Ltd bought a new stake in shares of Aspen Aerogels in the second quarter worth about $84,000. nVerses Capital LLC bought a new stake in shares of Aspen Aerogels in the second quarter worth about $95,000. Quent Capital LLC bought a new stake in shares of Aspen Aerogels in the third quarter worth about $118,000. Point72 DIFC Ltd bought a new stake in shares of Aspen Aerogels in the second quarter worth about $121,000. Finally, Public Employees Retirement Association of Colorado bought a new stake in shares of Aspen Aerogels in the second quarter worth about $145,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Insider Buying and Selling at Aspen Aerogels

In other news, CEO Donald R. Young sold 63,355 shares of the firm’s stock in a transaction that occurred on Monday, September 30th. The stock was sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the sale, the chief executive officer now directly owns 483,640 shares of the company’s stock, valued at $14,523,709.20. This trade represents a 11.58 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $30.14, for a total value of $978,495.10. Following the completion of the sale, the chief financial officer now directly owns 20,790 shares of the company’s stock, valued at approximately $626,610.60. The trade was a 60.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 4.30% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have issued reports on ASPN. HC Wainwright restated a “buy” rating and issued a $30.00 price target on shares of Aspen Aerogels in a report on Wednesday, October 16th. TD Cowen increased their price objective on Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a report on Tuesday, August 20th. Piper Sandler decreased their price objective on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a report on Tuesday, October 22nd. Roth Mkm decreased their price objective on Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a report on Friday, November 8th. Finally, Benchmark reiterated a “buy” rating and set a $14.00 price objective on shares of Aspen Aerogels in a report on Thursday, August 8th. One investment analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $28.70.

Aspen Aerogels Stock Down 2.7 %

ASPN stock opened at $15.12 on Friday. The company has a quick ratio of 2.82, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The business has a 50 day moving average price of $22.44 and a two-hundred day moving average price of $24.67. The company has a market cap of $1.24 billion, a price-to-earnings ratio of 1,513.01 and a beta of 2.21. Aspen Aerogels, Inc. has a twelve month low of $9.89 and a twelve month high of $33.15.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.